Latest news with #Versius
Yahoo
10-04-2025
- Business
- Yahoo
SoftBank Bets $200M On CMR Surgical, The UK Startup Taking On $178B Intuitive With Robots That Have Performed 30,000 Surgeries
In the world of medical tech-dominated by giants, one UK-based startup is going for the jugular. CMR Surgical just got itself more than $200 million in new capital to pump the pedal down on a global rollout of its surgical robotics system and, even more daring, to make a serious dent in the U.S. market, where $180 billion kingpin Intuitive Surgical reigns. With heavyweight backers like SoftBank, LightRock, Ally-Bridge, and a $68 million chunk of debt funding from Trinity Capital, the round signals deep-pocketed belief in CMR Surgical's trajectory. According to Sifted, this new cash pile brings the company's total raised to north of $1 billion, putting it squarely in unicorn territory, with a $3 billion valuation to match. Don't Miss: Deloitte's fastest-growing software company partners with Amazon, Walmart & Target – CMR Surgical is not exactly playing small ball. It's the best-capitalized surgical robots startup on earth, according to Dealroom. Since beginning its operations in 2014, it has raised more than most startups dream of raising. Its last large haul was a $600 million Series D round in 2021, which increased the startup's valuation tremendously. In 2023, the company also secured a $170 million convertible loan note. Patrick Vallance, UK science minister, said in a statement released by the company, 'This successful funding round of more than $200 million is a clear vote of confidence in the company, the potential of surgical robotics, and in the UK's life science ecosystem, which continues to produce innovative companies at an impressive rate.' Trending: Hasbro, MGM, and Skechers trust this AI marketing firm — . The centerpiece of CMR Surgical's aspiration is Versius, a robotic surgery platform for trials in colorectal, gynecology, thoracic, urology, and general soft tissue procedures. It has already begun making an impact where used, with over 30,000 procedures carried on around the world. Versius helps with instruments like endoscopes, forceps, and scissors, but it also records and feeds back surgical data to staff in real time, converting the operating room into something resembling a high-precision data level of integration is a big part of why the robot is now the world's second most-adopted soft tissue surgical robot, second only to Intuitive Surgical's long-established Surgical knows that it faces a turning point. 'We are now at a pivotal stage, poised to capitalize on significant opportunities for market expansion, including in the U.S. while continuing to penetrate deeper into existing markets,' CEO Massimiliano Colella said. Now that the company has a new war chest, it is preparing for a real push. Although it's topping the funding charts in Europe, it's not alone in the wider race to use robotic surgery. DistalMotion, based in Switzerland raised $150 million in 2023. The same year, Moon Surgical from France raised $55 million, and in 2024, Italy's Medical Microinstruments picked up $110 million. CMR Surgical's entry into the U.S. indicates an intent to disrupt the status quo. The competition in surgical robotics is entering a new, more decisive phase, with $200 million in new funding to enable its next stage of growth. Read Next:'Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report TESLA (TSLA): Free Stock Analysis Report This article SoftBank Bets $200M On CMR Surgical, The UK Startup Taking On $178B Intuitive With Robots That Have Performed 30,000 Surgeries originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio
Yahoo
04-04-2025
- Business
- Yahoo
CMR secures over $200m to commercialise surgical robotic system
CMR Surgical has completed a financing round of more than $200m, combining equity and debt capital to expedite the commercialisation of its Versius Surgical Robotic System, particularly focusing on the US market. Through these funds, the company also aims to bolster its growth strategy. The financing round is supported by all current investors and includes a debt investment from alternative asset manager Trinity Capital, which has pledged up to $68.75m in growth capital to the company as part of this current financing initiative. The funds will also support ongoing innovation and product development, including the introduction of the enhanced Versius Plus. Armentum Partners served as the company's financial adviser for the debt financing of the funding round. Deployed in more than 30,000 surgeries across over 30 nations so far, the Versius system aims to enhance surgical procedures. It received de novo marketing clearance from the US Food and Drug Administration (FDA) last year for cholecystectomy procedures in adults aged over 22. Versius 'biomimics' the arm of the human, offering surgeons dexterity and precision with fully wristed, small instruments. CMR is anticipating the broadening of its clinical footprint through two ongoing trials, a multi-centre prospective study of Versius in paediatric surgery and a transoral robotic surgery (TORS) study, showcasing the system's 'versatility' in surgical applications. CMR Surgical CEO Massimiliano Colella said: 'We are now at a pivotal stage, poised to capitalise on significant opportunities for market expansion, including in the US, while continuing to penetrate deeper into existing markets. 'I would like to give thanks to our chief financial officer, Andre Nel, and the team for securing this financing to provide the foundation for realising our strategic vision of making robotic-assisted surgery accessible to all patients who need it whilst accelerating future product development.' With its headquarters in the UK, CMR is collaborating with surgeons and hospitals to make robotic minimal-access surgery widely 'affordable' and 'accessible'. "CMR secures over $200m to commercialise surgical robotic system" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
03-04-2025
- Business
- Yahoo
CMR Surgical secures $200M for US robot rollout
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. CMR Surgical said Wednesday it closed a financing round worth more than $200 million to support commercializing the robot maker's Versius soft tissue system. The Cambridge, U.K.-based company now has its sights on the U.S. market, after winning Food and Drug Administration de novo authorization for the robot in October with an initial indication for gallbladder removal surgery. CMR plans to use the new funds to expand its worldwide rollout of Versius to hospitals, with a 'major focus' in the U.S., and to advance innovation and product development in surgical robotics. CMR, one of multiple companies competing for a portion of the growing market in robotically assisted surgery, claims that Versius is the second most utilized soft tissue robot worldwide, after industry leader Intuitive Surgical's da Vinci system. Mark Slack, CMR co-founder and chief medical officer, told MedTech Dive last year that new competition will be healthy for the market. The company built its base in global markets before preparing to compete with Intuitive on its home turf in the U.S., Slack said. CEO Massimiliano Colella, in a statement Wednesday, said CMR is focused on further penetration of existing markets in addition to the U.S. launch. 'We are now at a pivotal stage, poised to capitalise on significant opportunities for market expansion,' Colella said. Versius has been used to complete more than 30,000 surgical cases globally in more than 30 countries, across specialities including colorectal, general, gynecology, thoracic and urology surgeries. The company is also studying use of the robot in pediatric surgery and other applications. The funding round combines equity and debt capital and is backed by new investor Trinity Capital and existing CMR investors, the company said. Recommended Reading 4 robotic surgery trends to watch in 2025
Express Tribune
15-02-2025
- Health
- Express Tribune
Top surgeons call for pooling robotic surgery resources
KARACHI: Top surgeons and healthcare specialists at a two-day international symposium on robotic surgery have called for pooling resources of advanced surgical expertise by collaborating and enhancing access to achieve the desired goal. The opening day of the symposium - which started at the SIUT on Friday - featured discussions and hands-on training on wide ranging topics of robotics by acclaimed surgeons and healthcare specialists. They highlighted the transformative impact of robotics on modern surgery, emphasising its precision, efficiency, and ability to improve outcomes. The SIUT, which is a pioneering institution in urology, nephrology, organ transplantation, and hepatobiliary care, has been at the forefront of robotic surgery in Pakistan since 2017. It began its robotic surgery programme with a shared Da Vinci robotic system at Karachi's Civil Hospital and performed over 600 procedures. In 2021, the SIUT established its own Kassim Parekh Robotic and Laparoscopy Unit, featuring the Versius robotic surgical system, which has performed over 2,000 surgeries in urological, hepatobiliary, and colorectal segment of surgeries since then.
Yahoo
30-01-2025
- Health
- Yahoo
Can robots like Roxy revolutionise cancer surgery?
In operating theatre D at Glasgow's Royal Infirmary, gynaecological oncologist Dr Kevin Burton is directing four arms of a robot, affectionately named Roxy. The robot's mechanical arms, with surgical instruments attached to them, have been placed inside Dr Burton's patient through small cuts in the abdomen. The surgeon crosses the operating theatre to a console that would look more at home in an arcade and sits down. Dr Burton looks through a viewfinder and, with a joystick and foot pedals, he begins manipulating instruments. He is entirely in control of the robot as he cuts through tissue, avoiding important nerves and blood vessels as he searches deep into the pelvis for potentially cancerous lymph nodes. It is now more than five years since I first witnessed robot surgeons in action at the Golden Jubilee hospital in Clydebank. Surgeons say the contribution of robotic assisted surgery since then cannot be overstated. This week, First Minister John Swinney spoke at Scotland's National Robotarium to pledge that innovation and technology would be one of three key platforms for reforming the NHS. Artificial intelligence is the latest tool to assist with diagnostics, and a new digital app is promised to improve patient access. But what role might robots like Roxy play? Robotic surgery has been expanding in Scotland since it was first introduced in Grampian in 2015. Companies such as Versius, Mako and Rosa have supplied robots to health boards to assist with specialties such as thoracic, urology and pancreatic surgery. More recently some hospitals are using robots for orthopaedics. In 2021, the Scottish government invested £20m purchasing 12 da Vinci robots, primarily to develop cancer surgery, particularly in areas such as womb cancer or bowel cancer, the specialisms with the highest rates of open surgery. Surgeons say robotic assisted surgery (RAS) is transforming their ability to perform delicate and complex cancer surgery - with faster recovery for patients. But so far RAS is responsible for only around 1% of the total number of operations carried out on the NHS in Scotland and further investment would be expensive, with the cost of a da Vinci robot in the region of £1.7m plus running costs. Prof Graham Mackay is the clinical lead for the West of Scotland Cancer Centre and also a colorectal surgeon. He tells me that across Scotland they are seeing huge benefits from RAS. Rates of open surgery have dropped from about 70% to 30% in the past three years and it has almost halved the length of stay in hospital for patients, who also experience fewer complications. Prof Mackay says expanding the programme to other areas would help ease pressure on hospitals. "There are still a number of hospitals that don't have this technology," he says. "There are other cancer types which we're not treating yet by this and certainly from what we've seen in bowel cancer, this has really been the biggest step forward in surgical care that I've seen during my career. "What we want is that for all cancer patients, where they can benefit from it, to be benefiting." Isobel Morrison is one patient who has benefited from RAS. The 84-year-old required a hysterectomy to treat womb cancer but thanks to Roxy, was able to get home the day after her surgery in time to celebrate her 60th wedding anniversary. Isobel said: "I called him the Tin Man, and just said he'd done a good job. "I woke up, and didn't realise I'd even had it, "When the doctors happened to be in the ward, I said 'Excuse me, have I had my operation? And they said yes'. "So then I got home the next day, and I felt absolutely fine." Back in surgery and Dr Burton's operation has reached a delicate stage. Lymph nodes are cut away, and, still inside the patient's body, they are neatly put into a bag that will be removed by theatre nurses through the vagina. Dr Burton says the robot is "fantastic" and has "massive advantages" over traditional open or keyhole surgery. He says: "Robotic surgery gives you a really immersed close-up view, a really steady view, and has a 3D element to the vision which allows you do really complex tasks." He says higher obesity rates have been directly linked to an increase in gynaecological cancers and robotic assisted surgery enables surgeons to operate on patients who are so overweight that they would previously have been considered inoperable. Dr Burton says that without doubt RAS has the potential to save money for the NHS. "If we can get patients in hospital for less time, that frees up more beds for patients," he says. "So when you get a winter bed crisis, for example, we have more beds, we have more doctors and more nurses to actually deliver the care needed." In 2021, with post-pandemic backlogs mounting, the government saw robots as playing a central role in the remobilisation of the NHS. But technology moves fast and ministers need to choose which innovations will deliver most impact for less cost, when health board budgets are under more pressure than ever. The current plans talk of better use of data to increase productivity as well as innovations in genetic testing to better target of medications. Digital support for mental health, dermatology and the management of long-term conditions is also planned as well as a new Scottish health and social care app. So who can say whether more Roxies are set to join Scotland's NHS robot surgery team? The NHS robots performing major surgery Swinney pledges action to bring down NHS waits
